Cytogenetic and molecular analyses have provided pivotal biologic and clinical insights into pediatric neoplasia It is increasingly evident that genetic assays of various types can provide essential diagnostic or prognostic information about pediatric solid tumors and hematologic malignancies ( Tables 45-1 to 45-3 )